Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE

15 Mar 2016

Abstract excerpt

BACKGROUND: Pooled data from two large registries, Cubicin(®) Outcomes Registry and Experience (CORE; USA) and European Cubicin(®) Outcomes Registry and Experience (EU-CORE; Europe, Latin America, and Asia), were analyzed to determine the characteristics and clinical outcomes of daptomycin therapy in patients with Gram-positive infections across wide geographical regions. METHODS: Patients receiving at least one...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Orthopedic Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26976128
DOI: 10.1186/s12941-016-0130-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-COREPMID 26976128Read ↗

Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin.Semantic proximity Read ↗

Clinical Experience of Ceftaroline-Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational StudySemantic proximity Read ↗

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registrySemantic proximity Read ↗

Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-IDSemantic proximity Read ↗

Real‑world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram‑negative infections: Results from a retrospective studySemantic proximity Read ↗

Cefto-Reallife Study: Real World Data on the Use of Ceftobiprole in a Multicenter Spanish CohortSemantic proximity Read ↗

Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery - the prospective-randomized, microbiologist-blinded, stratified, superiority Trials - BAPTIST trialsSemantic proximity Read ↗

Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faeciumSemantic proximity Read ↗

A Comprehensive Analysis of Antimicrobial Agents Used in Surgical Prophylaxis in Clean Case: A ReviewSemantic proximity Read ↗

Comparative Efficacy and Safety of Generic vs Brand-Name Meropenem for Anti-infective Use in Real-worldSemantic proximity Read ↗

Osteoarticular prosthetic infection: how many patients are eligible for phage therapy? A French single-centre retrospective studySemantic proximity Read ↗

Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.